Neutropenia associated with the use of low-dose methotrexate in a peritoneal dialysis patient
暂无分享,去创建一个
U. Panzer | G. Wolf | S. Kluge | G. Kreymann
[1] H. Oldenhof,et al. Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis , 1988, Pharmaceutisch Weekblad.
[2] E. Hay,et al. Adverse reactions to disease-modifying anti-rheumatic drugs in clinical practice. , 2001, QJM : monthly journal of the Association of Physicians.
[3] M. Delbrück,et al. Lactic Acidosis Update for Critical Care Clinicians , 2001 .
[4] J. Lalau,et al. Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations. , 1999, Drug safety.
[5] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[6] A. Majid,et al. Bicarbonate haemodialysis as a treatment of metformin overdose. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] S. Sahn,et al. Opportunistic infection during treatment with low dose methotrexate. , 1994, American journal of respiratory and critical care medicine.
[8] L. Clancy,et al. Invasive pulmonary aspergillosis associated with low dose methotrexate therapy for rheumatoid arthritis: a case report of treatment with itraconazole. , 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[9] B. Strom,et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. , 1984, Annals of internal medicine.